Noteworthy, although in a different cancer model, UCA1 up-regulation was described to induce acquired resistance to EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutant NSCLC, and this was correlated to the activation of the AKT/mTOR pathway (63). The gene discussed is EGFR; the disease is cancer.